{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:11:43Z","timestamp":1769731903314,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["APQ-408675\/2018-7"],"award-info":[{"award-number":["APQ-408675\/2018-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-02167\u201321"],"award-info":[{"award-number":["APQ-02167\u201321"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R005850\/1"],"award-info":[{"award-number":["MR\/R005850\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.molimm.2023.01.011","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T19:02:52Z","timestamp":1675191772000},"page":"79-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Recombinant endonuclease III protein from Leishmania infantum associated with Th1-type adjuvants is immunogenic and induces protection against visceral leishmaniasis"],"prefix":"10.1016","volume":"155","author":[{"given":"Daniela P.","family":"Lage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda S.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila S.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danniele L.","family":"Vale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1via P.","family":"Linhares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamille M.O.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o A.","family":"Oliveira-da-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda F.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela A.G.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Ludolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grasiele S.V.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel S.","family":"Bandeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamil S.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Menezes-Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana C.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexsandro S.","family":"Galdino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron","family":"Christodoulides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Ch\u00e1vez-Fumagalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edvian T.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo A.F.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2023.01.011_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.actbio.2014.11.050","article-title":"Effective polymer adjuvants for sustained delivery of protein subunit vaccines","volume":"14","author":"Adams","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.molimm.2023.01.011_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004468","article-title":"Successful treatment of human visceral leishmaniasis restores antigen specific IFN-\u03b3, but not IL-10 production","volume":"10","author":"Adem","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2023.01.011_bib3","doi-asserted-by":"crossref","first-page":"3192960","DOI":"10.1155\/2021\/3192960","article-title":"FML\/QuilA-vaccinated dogs naturally infected with leishmania infantum: serum cytokines, clinicopathological profile, and parasitological parameters","volume":"2021","author":"Almeida","year":"2021","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.molimm.2023.01.011_bib4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/vaccines8020252","article-title":"Chimeric vaccines designed by immunoinformatics-activated poly-functional and memory T cells that trigger protection against experimental visceral leishmaniasis","volume":"8","author":"Brito","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.molimm.2023.01.011_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2334-5-113","article-title":"Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis","volume":"5","author":"Caldas","year":"2005","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.molimm.2023.01.011_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3024.2006.00817.x","article-title":"Immunohistological features of visceral leishmaniasis in BALB\/c mice","volume":"28","author":"Carri\u00f3n","year":"2006","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.molimm.2023.01.011_bib7","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.vaccine.2008.11.094","article-title":"A prime\/boost DNA\/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis.","volume":"27","author":"Carson","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2023.01.011_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.807172","article-title":"Role of virulence factors of trypanosomatids in the insect vector and putative genetic events involved in surface protein diversity","volume":"12","author":"Castro-Neto","year":"2022","journal-title":"Front Cell Infect. Microbiol"},{"key":"10.1016\/j.molimm.2023.01.011_bib9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1006\/cyto.1995.0088","article-title":"In vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmaniasis","volume":"7","author":"Cillari","year":"1995","journal-title":"Cytokine"},{"key":"10.1016\/j.molimm.2023.01.011_bib10","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"issue":"19","key":"10.1016\/j.molimm.2023.01.011_bib11","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.vaccine.2003.11.064","article-title":"Pluronic F127-based systemic vaccine delivery systems","volume":"22","author":"Coeshott","year":"2004","journal-title":"Vaccine"},{"issue":"2\u20133","key":"10.1016\/j.molimm.2023.01.011_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00430-021-00707-4","article-title":"Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis","volume":"210","author":"Costa","year":"2021","journal-title":"Med Microbiol Immunol."},{"key":"10.1016\/j.molimm.2023.01.011_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cellimm.2017.11.001","article-title":"Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis.","volume":"323","author":"Dias","year":"2018","journal-title":"Cell. Immunol."},{"issue":"4","key":"10.1016\/j.molimm.2023.01.011_bib14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1590\/0037-8682-0120-2016","article-title":"Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis","volume":"49","author":"Duarte","year":"2016","journal-title":"Rev. Soc. Bras. Med Trop."},{"key":"10.1016\/j.molimm.2023.01.011_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.vaccine.2020.11.064","article-title":"Lipophosphoglycan-3 protein from Leishmania infantum chagasi plus saponin adjuvant: a new promising vaccine against visceral leishmaniasis","volume":"39","author":"Emerick","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2023.01.011_bib16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fimmu.2014.00241","article-title":"Biomarkers of safety and immune protection for genetically modified live attenuated Leishmania vaccines against visceral leishmaniasis - discovery and implications","volume":"5","author":"Gannavaram","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2023.01.011_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117977","article-title":"The involvement of TLR2 and TLR4 in cytokine and nitric oxide production in visceral leishmaniasis patients before and after treatment with anti-leishmanial drugs","volume":"10","author":"Gatto","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.molimm.2023.01.011_bib18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1172\/JCI116570","article-title":"Interleukin 10 production correlates with pathology in human Leishmania donovani infections","volume":"92","author":"Ghalib","year":"1993","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.molimm.2023.01.011_bib19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1006\/meth.2001.1261","article-title":"An overview of real-time quantitative PCR: applications to quantify cytokine gene expression","volume":"25","author":"Giulietti","year":"2001","journal-title":"Methods"},{"issue":"44","key":"10.1016\/j.molimm.2023.01.011_bib20","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1016\/j.vaccine.2007.08.009","article-title":"Mota e Castro LL, de Lana M, Reis AB. Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs","volume":"25","author":"Giunchetti","year":"2007","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.molimm.2023.01.011_bib21","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1055\/s-0042-118387","article-title":"Saponin interactions with model membrane systems - langmuir monolayer studies, hemolysis and formation of ISCOMs","volume":"82","author":"Groot","year":"2016","journal-title":"Planta Med"},{"key":"10.1016\/j.molimm.2023.01.011_bib22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fcimb.2017.00200","article-title":"IFN-\u03b3, IL-2, IP-10, and MIG as biomarkers of exposure to Leishmania spp., and of cure in human visceral leishmaniasis","volume":"7","author":"Ibarra-Meneses","year":"2017","journal-title":"Front Cell Infect. Microbiol"},{"key":"10.1016\/j.molimm.2023.01.011_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005011","article-title":"Immunotherapeutic potential of eugenol emulsion in experimental visceral leishmaniasis.","volume":"10","author":"Islamuddin","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"9","key":"10.1016\/j.molimm.2023.01.011_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108556","article-title":"Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis","volume":"9","author":"Jaiswal","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2023.01.011_bib25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.exppara.2015.03.027","article-title":"Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis","volume":"153","author":"Jesus-Pereira","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.molimm.2023.01.011_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/S0169-409X(02)00018-2","article-title":"Pluronic block copolymers: novel functional molecules for gene therapy","author":"Kabanov","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.molimm.2023.01.011_bib27","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1186\/s12879-014-0653-6","article-title":"Role of CD8(+) T cells in protection against Leishmania donovani infection in healed visceral leishmaniasis individuals","volume":"14","author":"Kaushal","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.molimm.2023.01.011_bib28","first-page":"30","article-title":"Prophylactic interferon-gamma and interleukin-17 facilitate parasite clearance in experimental visceral leishmaniasis.","volume":"9","author":"Kumar","year":"2019","journal-title":"Trop. Parasitol."},{"issue":"3","key":"10.1016\/j.molimm.2023.01.011_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2014.4","article-title":"Vaccines to prevent leishmaniasis","volume":"3","author":"Kumar","year":"2014","journal-title":"Clin. Transl. Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2023.01.011_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030746","article-title":"Leishmania donovani: immunostimulatory cellular responses of membrane and soluble protein fractions of splenic amastigotes in cured patient and hamsters","volume":"7","author":"Kumari","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2023.01.011_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152905","article-title":"Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: a review","volume":"60","author":"Lacaille-Dubois","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.molimm.2023.01.011_bib32","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1017\/S0031182019000714","article-title":"Screening diagnostic candidates from Leishmania infantum proteins for human visceral leishmaniasis using an immunoproteomics approach","volume":"146","author":"Lage","year":"2019","journal-title":"Parasitology"},{"key":"10.1016\/j.molimm.2023.01.011_bib33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/vaccines8020289","article-title":"Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis","volume":"8","author":"Lage","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.molimm.2023.01.011_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2022.106412","article-title":"A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantum","volume":"230","author":"Machado","year":"2022","journal-title":"Acta Trop."},{"issue":"3","key":"10.1016\/j.molimm.2023.01.011_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002148","article-title":"Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis","volume":"7","author":"Martins","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2023.01.011_bib36","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3389\/fimmu.2015.00524","article-title":"Kinetoplastid membrane protein-11 as a vaccine candidate and a virulence factor in leishmania","volume":"6","author":"Mendon\u00e7a","year":"2015","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2023.01.011_bib37","first-page":"4074357","volume":"2018","author":"Mishra","year":"2018","journal-title":"Oxid. Stress-Mediat. overexpression uracil DNA glycosylase Leishmania donovani confers Toler. antileishmanial Drugs Oxid. Med. Cell. Long."},{"issue":"6","key":"10.1016\/j.molimm.2023.01.011_bib38","doi-asserted-by":"crossref","first-page":"e02360","DOI":"10.1128\/AAC.02360-16","article-title":"Meglumine Antimoniate (Glucantime) causes oxidative stress-derived DNA damage in BALB\/c mice infected by leishmania (Leishmania) infantum","volume":"61","author":"Moreira","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molimm.2023.01.011_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/ijms19010129","article-title":"Small myristoylated protein-3, Identified as a potential virulence factor in Leishmania amazonensis, proves to be a protective antigen against visceral leishmaniasis.","volume":"19","author":"Oliveira","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molimm.2023.01.011_bib40","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1038\/s41598-020-61662-3","article-title":"Establishment, optimisation and quantitation of a bioluminescent murine infection model of visceral leishmaniasis for systematic vaccine screening","volume":"10","author":"Ong","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molimm.2023.01.011_bib41","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/j.vaccine.2021.04.004","article-title":"A chimeric vaccine combined with adjuvant system induces immunogenicity and protection against visceral leishmaniasis in BALB\/c mice","volume":"39","author":"Ostolin","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2023.01.011_bib42","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3389\/fimmu.2019.00813","article-title":"Nucleoside hydrolase NH 36: a vital enzyme for the leishmania genus in the development of T-cell epitope cross-protective vaccines","volume":"10","author":"Palatnik-de-Sousa","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2023.01.011_bib43","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1586\/14760584.7.6.833","article-title":"FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine.","volume":"7","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.molimm.2023.01.011_bib44","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.2147\/IJN.S103344","article-title":"Pluronic P123\/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells","volume":"11","author":"Pellosi","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.molimm.2023.01.011_bib45","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-3083.2005.01686.x","article-title":"Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome","volume":"62","author":"Peruhype-Magalh\u00e3es","year":"2005","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.molimm.2023.01.011_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: A 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2023.01.011_bib47","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.imbio.2017.10.043","article-title":"Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis","volume":"223","author":"Portela","year":"2018","journal-title":"Immunobiology"},{"key":"10.1016\/j.molimm.2023.01.011_bib48","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"Rijal","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"2\u20133","key":"10.1016\/j.molimm.2023.01.011_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00430-021-00703-8","article-title":"Potential biomarkers of immune protection in human leishmaniasis","volume":"210","author":"Rostami","year":"2021","journal-title":"Med Microbiol Immunol."},{"key":"10.1016\/j.molimm.2023.01.011_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.624009","article-title":"Role of cytokines in experimental and human visceral leishmaniasis","volume":"11","author":"Samant","year":"2021","journal-title":"Front Cell Infect. Microbiol"},{"key":"10.1016\/j.molimm.2023.01.011_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104745","article-title":"Leishmania eukaryotic elongation factor-1 beta protein is immunogenic and induces parasitological protection in mice against Leishmania infantum infection","volume":"151","author":"Santos","year":"2021","journal-title":"Microb. Pathog."},{"issue":"12","key":"10.1016\/j.molimm.2023.01.011_bib52","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1080\/21645515.2020.1833579","article-title":"Exploring the possible use of saponin adjuvants in COVID-19 vaccine","volume":"16","author":"Sharma","year":"2020","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.molimm.2023.01.011_bib53","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cyto.2018.07.005","article-title":"Visceral leishmaniasis: a novel nuclear envelope protein 'nucleoporins-93 (NUP-93)' from Leishmania donovani prompts macrophage signaling for T-cell activation towards host protective immune response.","volume":"113","author":"Singh","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.molimm.2023.01.011_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001874","article-title":"Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis","volume":"6","author":"Singh","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2023.01.011_bib55","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ddr.21684","article-title":"Recent strategies for the development of oral medicines for the treatment of visceral leishmaniasis","volume":"81","author":"Souza","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.molimm.2023.01.011_bib56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1051\/parasite\/2020027","article-title":"A clioquinol-containing Pluronic F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model","volume":"27","author":"Tavares","year":"2020","journal-title":"Parasite"},{"key":"10.1016\/j.molimm.2023.01.011_bib57","doi-asserted-by":"crossref","first-page":"750","DOI":"10.12688\/f1000research.11120.1","article-title":"Leishmaniasis: a review.","volume":"26","author":"Torres-Guerrero","year":"2017","journal-title":"F1000Res"},{"issue":"4","key":"10.1016\/j.molimm.2023.01.011_bib58","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3390\/vaccines3040803","article-title":"Micelle-based adjuvants for subunit vaccine delivery","volume":"3","author":"Trimaille","year":"2015","journal-title":"Vaccines"},{"key":"10.1016\/j.molimm.2023.01.011_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.748325","article-title":"Determinants of innate immunity in visceral leishmaniasis and their implication in vaccine development","volume":"12","author":"Volpedo","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.molimm.2023.01.011_bib60","unstructured":"World Health Organization, 2022. Leishmaniasis. http:\/\/www.who.int\/topics\/leishmaniasis\/en\/. Visited at 01\/18\/2022."},{"key":"10.1016\/j.molimm.2023.01.011_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104272","article-title":"IFN-gamma(+) CD4(+)T cell-driven prophylactic potential of recombinant LDBPK_252400 hypothetical protein of Leishmania donovani against visceral leishmaniasis.","volume":"361","author":"Yadav","year":"2021","journal-title":"Cell. Immunol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589023000214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589023000214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:44:39Z","timestamp":1758980679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589023000214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":61,"alternative-id":["S0161589023000214"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2023.01.011","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant endonuclease III protein from Leishmania infantum associated with Th1-type adjuvants is immunogenic and induces protection against visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2023.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}